Results 151 to 160 of about 1,472,593 (206)

A self-assembled protein nanocage as a universal influenza vaccine induces enhanced broadly cross-reactive immunity. [PDF]

Biomaterials
Park J, Wimberley SC, Pho T, Rodriguez-Otero MR, Champion JA.   +4 more
europepmc   +1 more source

Analyzing the Decision to Get Flu Shot: An Empirical Study [PDF]

Influenza vaccination has been shown to be cost effective in reducing morbidity and mortality and in decreasing work absenteeism and use of health-care resources.
Gregory Yom Din, Uri Benzion, Yoshiro Tsutsui, Shosh ShahrabaniAuthor-Name:   +3 more
core  

Development of an intranasal, universal influenza vaccine in an EU-funded public-private partnership: the FLUniversal consortium. [PDF]

Front Immunol
Cnossen VM, Moreira PCL, Engelhardt OG, Samolej J, Groeneveld GH, Jochems SP, Huisman W, Pedersen GK, Wørzner K, Recek L, Piccini G, Trombetta CM, Aspelund A, Hoag A, Reiter M, Wick C, Muster T, Kamerling IMC.   +17 more
europepmc   +1 more source

A bovine adenoviral-vector-based universal influenza vaccine confers protection against influenza A and B viruses in mice and ferrets. [PDF]

Mol Ther Nucleic Acids
Wang WC, Sayedahmed EE, Alhashimi M, Elkashif A, Gairola V, Murala MST, Sambhara S, Mittal SK.   +7 more
europepmc   +1 more source

Safety and Immunogenicity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, Co-Administered with Fluarix^® Tetra, a Seasonal Hemagglutinin-Based Vaccine. [PDF]

Vaccines (Basel)
Groth N, Bruhwyler J, Tourneur J, Piat E, Moris P, Le Vert A, Nicolas F.   +6 more
europepmc   +1 more source

Evaluation of Safety, Immunogenicity and Cross-Reactive Immunity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, in Older Adults. [PDF]

Vaccines (Basel)
Jacobs B, Leroux-Roels I, Bruhwyler J, Groth N, Waerlop G, Janssens Y, Tourneur J, De Boever F, Alhatemi A, Moris P, Le Vert A, Leroux-Roels G, Nicolas F.   +12 more
europepmc   +1 more source

Multi-Epitope Peptide-Based and Vaccinia-Based Universal Influenza Vaccine Candidates Subjected to Clinical Trials. [PDF]

Malays J Med Sci, 2020
Romeli S, Hassan SS, Yap WB.
europepmc   +1 more source

Health Policy and Technological Change: Evidence from the Vaccine Industry [PDF]

Rapid technological progress has been a defining feature of the medical sector over the last century, yet we know little about the determinants of the development of these new technologies.
Amy Finkelstein
core  

Dynamic Perspectives on the Search for a Universal Influenza Vaccine. [PDF]

J Infect Dis, 2019
Saad-Roy CM, McDermott AB, Grenfell BT.
europepmc   +1 more source

Plotting a route to a universal influenza vaccine [PDF]

The Lancet Infectious Diseases, 2018
openaire   +2 more sources